ALERTA SANITARIA
Providean Contendor 5
This vaccine belongs to the group
VACCINE AGAINST INFLUENZA, HERPES VIRUS, ENCEPHALOMYELITIS AND TETANUS IN EQUINES
Composition:
Each 1 ml dose prior to inactivation contains: Equine Influenza Virus strains (H3N8) A/eq/ARG/E/2345-1/12 (FLORIDA CLADE 1): (≥ 5000 HAU) and A/equi/Meath/07 (FLORIDA CLADE 2): (≥ 5000 UHA); Equine Herpes Virus – 1, Kentucky strain (≥106.5 TCID50%); Eastern (≥107.5 TCID50%) and Western (≥107.5 TCID50%) Equine Encephalomyelitis Virus, Tetanus Toxoid (≥ 100,000 LD50%), Adjuvant Aluminum Hydroxide Gel, Excipients q.s. to 1 ml.
Indications:
For the prevention or prophylaxis of Equine Influenza, Equine Herpes virus, Equine Encephalomyelitis and Equine Tetanus.
Dosage:
1 ml/dose. Apply intramuscularly only. Shake the vial before filling the syringe.
Guideline Immunization Schedule
Suggested immunization scheme
Primo-vaccinated animals: vaccinate from 3 months of age and revaccinate 30 days after the first dose. Future applications: once a year.
Pregnant females: previously vaccinated animals, 1 dose 30 days before delivery. Animals not previously vaccinated: 1 dose 60 days and 1 booster 30 days before giving birth.
The suggested scheme should be adapted to the recommendation of your veterinarian according to the particular needs of each region or farm. For horses in transit, vaccination against influenza must comply with current legislation; every 3 months.
Precautions and Warnings
Precautions and Warnings
Keep out of reach of children and domestic animals. Do not subject animals to stress and/or excessive work before and/or after vaccination. Do not administer in parasitized, malnourished, fatigued, or feverish animals, or animals on antibiotic and/or corticoid treatment. Apply this product under the supervision of a veterinary professional. The product can generate a slight local reaction at the application site that disappears progressively. In isolated cases, the vaccine can produce anaphylactic shock, in which case the veterinarian should apply epinephrine at 1‰.
Conservation
Between 2º and 8º C. Do not freeze. Do not expose to heat or sunlight. Used containers should be discarded according to local legislation.
